NEW YORK (GenomeWeb) – Synthetic Genomics and Archer Daniels Midland today announced a deal to commercialize Omega-3 docosahexaenoic acid (DHA) from algae.

Typically found in fish and seafood products, DHA has been studied for the role it plays in brain, heart, and eye health. Extracting DHA directly from algae grown in fermentation tanks yields a "highly purified" form of DHA, which can be used as a dietary supplement for humans and in animal feed, the partners said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.